Guidant Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Guidant Wealth Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-5	Closed	-$1K	–	246
2018 Q2	$1K	Buy	+5	New	+$1.03K	﹤0.01%	204

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Guidant Wealth Advisors's IDXX Position: Q3 2018 in Review

Guidant Wealth Advisors sold out of Idexx Laboratories (IDXX) in Q3 2018, closing a stake of 5 shares — an estimated $1K sold.

Guidant Wealth Advisors first reported a position in IDXX in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 697 funds tracked by Wall St. Rank hold IDXX as of Q3 2018.

Guidant Wealth Advisors reported no remaining Idexx Laboratories position as of Q3 2018 after selling out during the quarter.
Guidant Wealth Advisors sold 5 Idexx Laboratories shares in Q3 2018, an estimated $1K.
Guidant Wealth Advisors first reported a position in Idexx Laboratories in Q2 2018 and held it in 1 quarter.
Guidant Wealth Advisors's Idexx Laboratories position peaked at $1K in Q2 2018.
697 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2018.

Based on Guidant Wealth Advisors's 13F filing for Q3 2018, filed 9 Oct 2018.